AGEN EURO SECRETS

Emily Bodnar’s rating is predicated on the anticipation of important milestones for Agenus in the approaching calendar year, specifically the likely filing of the Biologics License Software (BLA) for his or her lead drug candidate, botensilimab (bot). Agenus has dosed over 900 patients with bot throughout numerous sound tumors, showing a motivati